Clinical Trial Update: Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating immunotherapy for relapse after allogeneic transplantation in acute myeloid leukemia, acute lymphoblastic leukemia, blast phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Blast Phase Chronic Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Emory University | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-08-18